2020
DOI: 10.1038/s41587-020-0720-z
|View full text |Cite
|
Sign up to set email alerts
|

Viability criteria assessment during liver machine perfusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
45
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 38 publications
(51 citation statements)
references
References 21 publications
0
45
0
Order By: Relevance
“…Two strategies appear. First, identify a large number of unspecific parameters and thresholds, requiring artificial intelligence to calculate sort of score points to decide, if a single organ could be used for transplantation [52]. Or second, an easy, cheap, and more precise approach using a few single tests of biomolecules, released from mitochondrial complex I, the key site, where the IRI cascade initiates [40,53,54].…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…Two strategies appear. First, identify a large number of unspecific parameters and thresholds, requiring artificial intelligence to calculate sort of score points to decide, if a single organ could be used for transplantation [52]. Or second, an easy, cheap, and more precise approach using a few single tests of biomolecules, released from mitochondrial complex I, the key site, where the IRI cascade initiates [40,53,54].…”
Section: Figurementioning
confidence: 99%
“…Multiple parameters to assess viability during machine perfusion have been suggested within the last 5 years. Today there is no widely accepted marker, which is reliable to provide enough confidence to accept a liver [52]. Two potential strategies are available.…”
Section: Summary and Future Perspectivementioning
confidence: 99%
“…This highlights that hepatocellular viability is likely physiologically separate from biliary/cholangiocyte viability and should be included in future trials to check viability. ( 3 )…”
Section: Author/center Publication No Of Patients Declined Livers Group Vs Standard Allocation Country/rate Of Decline Outcomesmentioning
confidence: 99%
“…This project awarded him and his mentees several awards and impactful articles. [4][5][6] Last but not least, Dr. Martins has championed diversity/ equity efforts at local and national levels. He has dedicated efforts to increasing diversity by actively participating in diversity/minorities committees of the United Network of Organ Sharing (UNOS), American Society of Transplant Surgeons.…”
Section: E D I T O R I a L Paulo Martins To Serve As An Associate Edimentioning
confidence: 99%
“…His team was the first to use machine preservation as a platform for gene silencing using siRNAs to alleviate organ ischemia reperfusion injury. This project awarded him and his mentees several awards and impactful articles 4‐6 …”
mentioning
confidence: 99%